These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17391572)

  • 61. Raising the bar: a comparative analysis of patients with early onset Alzheimer's disease.
    Rosness TA; Engedal K; Chemali Z
    Int Psychogeriatr; 2014 Dec; 26(12):2103-4. PubMed ID: 24472377
    [No Abstract]   [Full Text] [Related]  

  • 62. Defining and Measuring Outcomes in Alzheimer's Disease: Do We Agree? Proceedings of a conference. Washington, D.C., USA. September 11-12, 1996.
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 6():1-198. PubMed ID: 9498851
    [No Abstract]   [Full Text] [Related]  

  • 63. The search for diagnostic and progression markers in AD: so near but still too far?
    Black SE
    Neurology; 1999 May; 52(8):1533-4. PubMed ID: 10331672
    [No Abstract]   [Full Text] [Related]  

  • 64. Primary or secondary prevention for AD: who cares?
    Frisoni GB; Trojanowski JQ
    Lancet Neurol; 2012 Aug; 11(8):661-2. PubMed ID: 22705337
    [No Abstract]   [Full Text] [Related]  

  • 65. Alzheimer disease in 2016: Putting AD treatments and biomarkers to the test.
    Reiman EM
    Nat Rev Neurol; 2017 Feb; 13(2):74-76. PubMed ID: 28084326
    [No Abstract]   [Full Text] [Related]  

  • 66. (Un)Ethical Early Interventions in the Alzheimer's "Marketplace of Memory".
    George DR; Whitehouse PJ
    AJOB Neurosci; 2021; 12(4):245-247. PubMed ID: 34704904
    [No Abstract]   [Full Text] [Related]  

  • 67. Alzheimer disease: advances in pathogenesis, diagnosis, and therapy.
    Pasic MD; Diamandis EP; McLaurin J; Holtzman DM; Schmitt-Ulms G; Quirion R
    Clin Chem; 2011 May; 57(5):664-9. PubMed ID: 21310870
    [No Abstract]   [Full Text] [Related]  

  • 68. Defining and measuring outcomes in Alzheimer disease research: introduction and overview.
    Whitehouse P; Maslow K
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 6():1-6. PubMed ID: 9437441
    [No Abstract]   [Full Text] [Related]  

  • 69. Next Generation Brain Health Depends on Early Alzheimer Disease Diagnosis: From a Timely Diagnosis to Future Population Screening.
    De Roeck EE; Engelborghs S; Dierckx E
    J Am Med Dir Assoc; 2016 May; 17(5):452-3. PubMed ID: 26972349
    [No Abstract]   [Full Text] [Related]  

  • 70. Early Detection of AD Biomarkers and the Ethical Criteria for Screening Programs.
    Tromp K; Bunnik E; Smedinga M; Richard E; Schermer M
    AJOB Neurosci; 2021; 12(4):231-233. PubMed ID: 34704908
    [No Abstract]   [Full Text] [Related]  

  • 71. Biological markers as outcome measures for Alzheimer's disease interventions--real problems and future possibilities.
    Takeda M; Okochi M; Tagami S; Tanaka T; Kudo T
    Int Psychogeriatr; 2007 Jun; 19(3):391-400. PubMed ID: 17391572
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity.
    Hampel H; Mitchell A; Blennow K; Frank RA; Brettschneider S; Weller L; Möller HJ
    J Neural Transm (Vienna); 2004 Mar; 111(3):247-72. PubMed ID: 14991453
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Disease-modifying therapies for Alzheimer disease: challenges to early intervention.
    Cummings JL; Doody R; Clark C
    Neurology; 2007 Oct; 69(16):1622-34. PubMed ID: 17938373
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020.
    Hampel H; Lista S; Teipel SJ; Garaci F; Nisticò R; Blennow K; Zetterberg H; Bertram L; Duyckaerts C; Bakardjian H; Drzezga A; Colliot O; Epelbaum S; Broich K; Lehéricy S; Brice A; Khachaturian ZS; Aisen PS; Dubois B
    Biochem Pharmacol; 2014 Apr; 88(4):426-49. PubMed ID: 24275164
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genetic markers for diagnosis and pathogenesis of Alzheimer's disease.
    Kim DH; Yeo SH; Park JM; Choi JY; Lee TH; Park SY; Ock MS; Eo J; Kim HS; Cha HJ
    Gene; 2014 Jul; 545(2):185-93. PubMed ID: 24838203
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.